Cargando…
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056161/ https://www.ncbi.nlm.nih.gov/pubmed/36983604 http://dx.doi.org/10.3390/jpm13030422 |
_version_ | 1785016057484804096 |
---|---|
author | Popoviciu, Mihaela Simona Kaka, Nirja Sethi, Yashendra Patel, Neil Chopra, Hitesh Cavalu, Simona |
author_facet | Popoviciu, Mihaela Simona Kaka, Nirja Sethi, Yashendra Patel, Neil Chopra, Hitesh Cavalu, Simona |
author_sort | Popoviciu, Mihaela Simona |
collection | PubMed |
description | Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the ‘omics’, the individualization of therapy is not only closer to reality but also the need of the hour. |
format | Online Article Text |
id | pubmed-10056161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100561612023-03-30 Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine Popoviciu, Mihaela Simona Kaka, Nirja Sethi, Yashendra Patel, Neil Chopra, Hitesh Cavalu, Simona J Pers Med Review Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the ‘omics’, the individualization of therapy is not only closer to reality but also the need of the hour. MDPI 2023-02-26 /pmc/articles/PMC10056161/ /pubmed/36983604 http://dx.doi.org/10.3390/jpm13030422 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Popoviciu, Mihaela Simona Kaka, Nirja Sethi, Yashendra Patel, Neil Chopra, Hitesh Cavalu, Simona Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title_full | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title_fullStr | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title_full_unstemmed | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title_short | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine |
title_sort | type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056161/ https://www.ncbi.nlm.nih.gov/pubmed/36983604 http://dx.doi.org/10.3390/jpm13030422 |
work_keys_str_mv | AT popoviciumihaelasimona type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine AT kakanirja type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine AT sethiyashendra type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine AT patelneil type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine AT choprahitesh type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine AT cavalusimona type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine |